Sale of Angelico Ventures Shares according to SEC Regulation D
will start in:

About us
Angelico Ventures
Our mission and vision
Extend people's healthspan and lifespan. Become a global leader in changing the practice of healthcare.
Legal structure
Angelico Ventures is a USA limited liability company created for longevity industry consolidation.
Investment Focus
Healthcare IT/ AI, IoT devices, diagnostics, therapeutics, services impacting longevity.
Asset Management Fee
0.9% from assets under management and 19% from the capital increase.
Target Investment Return
3X in 5 years before taxes.
Target Fundraising
Over $100 million.
Yuriy Oreshin
Managing General Partner
Yuriy founded first in CIS life sciences boutique investment bank Angelico Ventures in 2008. Some of the deals included creation of Alvansa pharmaceutical holding with a total investment of $200 million and $58 million PIPE (Private investment in public equity) and scientific research collaboration deal for Affitech, NASDAQ OMX Copenhagen listed company focused on antibody therapeutics research for cancer treatment. Yuriy served as the CEO of subsidiary of CureLab Oncology Inc. a US based oncology gene therapy drug development company and is currently one of the company shareholders. He also worked as the Director of Licensing and Business Development at the Human Stem Cell Institute Inc. - top 5 company in the world that registered and brought to market gene therapy drug. Yuriy graduated from the Darla Moore School of Business, USC (University of South Carolina) specializing in Marketing and International Business with electives in Clinical Nutrition and Psychology.

Mikhail Pliss
General Partner
Mikhail worked for Microsoft, Public Sector, Healthcare; Oracle Netherlands BV, Public Sector, Healthcare.

Philips Healthcare, Healthcare Transformation Services; as well as participated in McKinsey and Company projects.

25+ years of professional experience in IT.

16+ years management C-level or Senior Consulting level, leadership skills and team management.

7+ years in IT in Healthcare and social sphere.

6+ years in successful sales in strategic, management and IT consulting in healthcare and social sphere.

Dr. Robert Goldman
General Partner
Dr. Goldman, holds two Physician & Surgeon Medical Degrees and two Medical Doctorates and has served as a Senior Fellow at the Lincoln Filene Center, Tufts University and as an Affiliate at the Philosophy of Education Research Center, Graduate School of Education, Harvard University. He co-founded and served as Chairman of the Board of Life Science Holdings and Organ Inc, biomedical R&D companies with over 150 medical patents under development in the areas of brain resuscitation, trauma and emergency medicine, organ transplant and blood preservation technologies. These led to the formation of Organ Recovery Systems Inc. and then LifeLine Scientific Inc, a Public Company, which became a world leader in organ preservation and transport. He has overseen cooperative research agreement development programs in conjunction with the American National Red Cross, NASA, the Department of Defense, and the FDA's Center for Devices & Radiological Health.

Our Process
We do global Business, Technology, Investment research to help you make solid investment & divestment decisions in competitive business environment.
Strategy Development
We develop market dominance strategies including industry consolidation and M&A.
Investment and Management
We help great entrepreneurs fund and develop great companies at all stages to dominate global marketplace.
Portfolio Companies
Why choose us?
High Performance
Our Team members created a multi-billion dollar anti-aging medicine industry. Raised over $358 million for companies of their clients and their our own healthcare ventures.
High Integrity
We are always ready to provide our sincere advice.
Healthcare Focused Approach
Our Team works to extend lifespan and healthpan for our families and your families putting health first.
Contact us
Made on